Champions Biotechnology, Inc. , a company engaged in the development of advanced preclinical platforms and tumor specific data to enhance the value of oncology drugs, today announced its financial results for the third  fiscal quarter ended January 31, 2010.  Full details of Company’s financial results are available in the Company’s Form 10-Q at www.championsbiotechnology.com …
Read more here:
Champions Biotechnology Reports Fiscal 2010 Third Quarter Financial Results (PR Newswire via Yahoo! Finance)
Biolexis is a premiere online resource for life sciences professionals, investors and entrepreneurs. The site offers personalized information biotechnology news and other biotechnology resources. Information is further organized by industry sector, therapeutic areas, technology focus, service orientation, and location. With Biolexis, you can: access over 5,000 biotechnology news strories and biotechnology articles. Search biotech company information, biotech news, biotech articles and biotech related press releases.